Cardlytics(CDLX)

Search documents
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release
GlobeNewswire News Room· 2024-10-23 20:01
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that its financial results for the third quarter ending September 30, 2024 will be released on November 6, 2024, after market close. The results will be discussed via conference call at 5:00 PM ET / 2:00 PM PT. The company invites investors to join a live audio webcast at http://ir.cardlytics.com/ or to dial-in by registering at this link. A replay will be available ...
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2024-08-19 20:05
ATLANTA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that, on August 19, 2024, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 49,900 restricted stock units of Cardlytics to seven newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics ...
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
GlobeNewswire News Room· 2024-08-15 20:00
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX. Investigation Details Cardlytics claimed to the market that its technology initiatives were "really paying off." How ...
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
Prnewswire· 2024-08-14 15:22
LOS ANGELES, Aug. 14, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cardlytics claimed to the market that its technology initiatives were "really ...
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
GlobeNewswire News Room· 2024-08-13 22:34
SAN FRANCISCO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/cdlx Contact the Firm Now: CDLX@hbsslaw.com 844-916-0895 Investigation Into Cardlytics, Inc. (CDLX): Cardlytics Inc. is facing scrutiny from prominent shareholder rights firm Hagens B ...
SHAREHOLDER ALERT: Investigation Into Cardlytics, Inc. (CDLX) Announced byHolzer & Holzer, LLC
GlobeNewswire News Room· 2024-08-12 14:26
ATLANTA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) complied with federal securities laws. On August 7, 2024, Cardlytics reported financial results for its second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating "our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives." Following this news, the price of the Compa ...
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cardlytics, Inc. on Behalf of Cardlytics Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-08-11 01:00
NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX) on behalf of Cardlytics stockholders. Our investigation concerns whether Cardlytics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 7, 2024, Cardlytics announced its second quarter 202 ...
Johnson Fistel Begins Investigation into Cardlytics Following a Significant Drop in the Company's Stock
GlobeNewswire News Room· 2024-08-08 13:43
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Cardlytics, Inc. (NASDAQ: CDLX) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Cardlytics securities? If you purchased securities and suffered losse ...
Cardlytics(CDLX) - 2024 Q2 - Earnings Call Transcript
2024-08-08 00:24
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Nick Lynton - Chief, Legal & Privacy Officer Jack Klinck - Chairperson of the Board Amit Gupta - Chief Operating Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Jaeson Schmidt - Lake Street Capital Markets Kyle Peterson - Needham Luke Horton - Northland Capital Markets Jason Kreyer - Craig-Hallum Operator Good day, and thank you for standing by. Welcome to the Cardlyti ...
Cardlytics(CDLX) - 2024 Q2 - Quarterly Report
2024-08-07 20:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...